본문으로 건너뛰기

참고문헌

📍 현재 위치: 이 책 전체의 근거를 한곳에 모아 둔 참고문헌입니다.

이 책의 모든 본문 인용([1]과 같은 대괄호 표기)은 여기에서 장별로 정리되어 있습니다. 이 페이지의 번호는 각 장의 [N] 표기와 일치합니다. 원자료가 영어이므로 서지 항목은 원문 그대로 표기합니다.

머리말​

  1. Rathore AS, Winkle H. (2009). Quality by design for biopharmaceuticals. Nature Biotechnology 27(1):26-34. https://doi.org/10.1038/nbt0109-26
  2. ICH (International Council for Harmonisation). (2009). ICH Harmonised Tripartite Guideline Q8(R2): Pharmaceutical Development. ICH, Current Step 4 version, August 2009. https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf
  3. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data 3:160018. https://doi.org/10.1038/sdata.2016.18
  4. Smith B, Ashburner M, Rosse C, et al. (2007). The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nature Biotechnology 25(11):1251-1255. https://doi.org/10.1038/nbt1346

1장 — 상위 척추: 지속체, 발생체, 그리고 모두가 BFO 위에 쌓는 이유​

  1. ISO/IEC (International Organization for Standardization / International Electrotechnical Commission). (2021). ISO/IEC 21838-2:2021 — Information technology — Top-level ontologies (TLO) — Part 2: Basic Formal Ontology (BFO). ISO/IEC, Geneva. https://www.iso.org/standard/74572.html
  2. Arp R, Smith B, Spear AD. (2015). Building Ontologies with Basic Formal Ontology. The MIT Press, Cambridge, MA, 248 pp., ISBN 978-0-262-52781-1. https://doi.org/10.7551/mitpress/9780262527811.001.0001
  3. Smith B, Ashburner M, Rosse C, et al. (2007). The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nature Biotechnology 25(11):1251-1255. https://doi.org/10.1038/nbt1346
  4. Smith B, Ceusters W, Klagges B, Köhler J, Kumar A, Lomax J, Mungall C, Neuhaus F, Rector AL, Rosse C. (2005). Relations in biomedical ontologies. Genome Biology 6(5):R46. https://doi.org/10.1186/gb-2005-6-5-r46
  5. Kulvatunyou BS, Wallace E, Kiritsis D, Smith B, Will C. (2018). The Industrial Ontologies Foundry Proof-of-Concept Project. In: Moon I, et al. (eds), Advances in Production Management Systems (APMS 2018), IFIP AICT 536, Springer, pp. 402-409. https://doi.org/10.1007/978-3-319-99707-0_50

2장 — 클래스, 관계, 공리: 어휘 구축하기​

  1. W3C OWL Working Group. (2012). OWL 2 Web Ontology Language Primer (Second Edition). W3C Recommendation, 11 December 2012. https://www.w3.org/TR/owl2-primer/
  2. Cyganiak R, Wood D, Lanthaler M (eds). (2014). RDF 1.1 Concepts and Abstract Syntax. W3C Recommendation, 25 February 2014. https://www.w3.org/TR/rdf11-concepts/
  3. Knublauch H, Kontokostas D (eds). (2017). Shapes Constraint Language (SHACL). W3C Recommendation, 20 July 2017. https://www.w3.org/TR/shacl/
  4. Musen MA. (2015). The Protégé project: A look back and a look forward. AI Matters 1(4):4-12. https://doi.org/10.1145/2757001.2757003
  5. Baader F, Calvanese D, McGuinness DL, Nardi D, Patel-Schneider PF (eds). (2003). The Description Logic Handbook: Theory, Implementation and Applications. Cambridge University Press, ISBN 978-0-521-78176-3. https://doi.org/10.1017/CBO9780511711787

3장 — 식별자와 단위: IRI, QUDT, 그리고 타입이 부여된 값​

  1. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data 3:160018. https://doi.org/10.1038/sdata.2016.18
  2. Cyganiak R, Wood D, Lanthaler M (eds). (2014). RDF 1.1 Concepts and Abstract Syntax. W3C Recommendation, 25 February 2014. https://www.w3.org/TR/rdf11-concepts/
  3. QUDT.org. (2024). QUDT — Quantities, Units, Dimensions and Types Ontology (Version 2.1). QUDT.org. https://qudt.org/
  4. Schadow G, McDonald CJ. (2017). The Unified Code for Units of Measure (UCUM), Revision 2.1. Regenstrief Institute, Indianapolis, IN. https://ucum.org/
  5. Halpin H, Hayes PJ, McCusker JP, McGuinness DL, Thompson HS. (2010). When owl:sameAs Isn't the Same: An Analysis of Identity in Linked Data. In: The Semantic Web — ISWC 2010, LNCS 6496, Springer, pp. 305-320. https://doi.org/10.1007/978-3-642-17746-0_20

4장 — 표적과 제품 개념 모델링하기​

  1. Bandrowski A, Brinkman R, Brochhausen M, et al. (2016). The Ontology for Biomedical Investigations. PLoS ONE 11(4):e0154556. https://doi.org/10.1371/journal.pone.0154556
  2. Ashburner M, Ball CA, Blake JA, et al. (2000). Gene Ontology: tool for the unification of biology. Nature Genetics 25(1):25-29. https://doi.org/10.1038/75556
  3. Natale DA, Arighi CN, Blum M, et al. (2017). Protein Ontology (PRO): enhancing and scaling up the representation of protein entities. Nucleic Acids Research 45(D1):D339-D346. https://doi.org/10.1093/nar/gkw1075
  4. Schriml LM, Munro JB, Schor M, et al. (2022). The Human Disease Ontology 2022 update. Nucleic Acids Research 50(D1):D1255-D1261. https://doi.org/10.1093/nar/gkab1063
  5. Smith B, Ashburner M, Rosse C, et al. (2007). The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nature Biotechnology 25(11):1251-1255. https://doi.org/10.1038/nbt1346

5장 — 분자 모델링하기: 서열, 모달리티, 개발성​

  1. Natale DA, Arighi CN, Blum M, et al. (2017). Protein Ontology (PRO): enhancing and scaling up the representation of protein entities. Nucleic Acids Research 45(D1):D339-D346. https://doi.org/10.1093/nar/gkw1075
  2. Jain T, Sun T, Durand S, et al. (2017). Biophysical properties of the clinical-stage antibody landscape. Proceedings of the National Academy of Sciences 114(5):944-949. https://doi.org/10.1073/pnas.1616408114
  3. Raybould MIJ, Marks C, Krawczyk K, et al. (2019). Five computational developability guidelines for therapeutic antibody profiling. Proceedings of the National Academy of Sciences 116(10):4025-4030. https://doi.org/10.1073/pnas.1810576116
  4. Bandrowski A, Brinkman R, Brochhausen M, et al. (2016). The Ontology for Biomedical Investigations. PLoS ONE 11(4):e0154556. https://doi.org/10.1371/journal.pone.0154556

6장 — 세포주와 세포은행 계보 모델링하기​

  1. Federhen S. (2012). The NCBI Taxonomy database. Nucleic Acids Research 40(D1):D136-D143. https://doi.org/10.1093/nar/gkr1178
  2. Sarntivijai S, Lin Y, Xiang Z, et al. (2014). CLO: The Cell Line Ontology. Journal of Biomedical Semantics 5:37. https://doi.org/10.1186/2041-1480-5-37
  3. ICH (International Council for Harmonisation). (1997). ICH Harmonised Tripartite Guideline Q5D: Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products. ICH, Current Step 4 version, July 1997. https://database.ich.org/sites/default/files/Q5D%20Guideline.pdf
  4. Wurm FM. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology 22(11):1393-1398. https://doi.org/10.1038/nbt1026
  5. Xu X, Nagarajan H, Lewis NE, et al. (2011). The genomic sequence of the Chinese hamster ovary (CHO-K1) cell line. Nature Biotechnology 29(8):735-741. https://doi.org/10.1038/nbt.1932

7장 — 설계 공간 모델링하기: CPP, CQA, 그래프로서의 QbD​

  1. ICH (International Council for Harmonisation). (2009). ICH Harmonised Tripartite Guideline Q8(R2): Pharmaceutical Development. ICH, Current Step 4 version, August 2009. https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf
  2. ICH (International Council for Harmonisation). (2023). ICH Harmonised Guideline Q9(R1): Quality Risk Management. ICH, Current Step 4 version, January 2023. https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2023_0126_0.pdf
  3. ICH (International Council for Harmonisation). (2008). ICH Harmonised Tripartite Guideline Q10: Pharmaceutical Quality System. ICH, Current Step 4 version, June 2008. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf

8장 — 분석법과 결과 모델링하기: Allotrope와 OBI​

  1. Allotrope Foundation. (2024). Allotrope Framework: Allotrope Foundation Ontologies (AFO) and Allotrope Data Format (ADF). Allotrope Foundation. https://www.allotrope.org/
  2. Bandrowski A, Brinkman R, Brochhausen M, et al. (2016). The Ontology for Biomedical Investigations. PLoS ONE 11(4):e0154556. https://doi.org/10.1371/journal.pone.0154556
  3. ASTM International, Subcommittee E13.15. (2023). AnIML — Analytical Information Markup Language. ASTM International, West Conshohocken, PA. https://www.animl.org/

9장 — 레시피와 기술 이전 모델링하기: 이식 가능한 공정 지식​

  1. IEC (International Electrotechnical Commission). (2010). IEC 61512-1: Batch control — Part 1: Models and terminology (ISA-88). IEC, Geneva. https://webstore.iec.ch/publication/5529
  2. IEC (International Electrotechnical Commission). (2013). IEC 62264-1: Enterprise-control system integration — Part 1: Models and terminology (ISA-95). IEC, Geneva. https://webstore.iec.ch/publication/21241
  3. MESA International. (2013). B2MML — Business To Manufacturing Markup Language. Manufacturing Enterprise Solutions Association (MESA). https://www.mesa.org/topics-resources/b2mml/
  4. ICH (International Council for Harmonisation). (2008). ICH Harmonised Tripartite Guideline Q10: Pharmaceutical Quality System. ICH, Current Step 4 version, June 2008. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf
  5. ICH (International Council for Harmonisation). (2019). ICH Harmonised Guideline Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. ICH, Current Step 4 version, November 2019. https://database.ich.org/sites/default/files/Q12_Guideline_Step4_2019_1119.pdf

10장 — 시드 트레인과 계보의 시작 모델링하기​

  1. Wurm FM. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology 22(11):1393-1398. https://doi.org/10.1038/nbt1026
  2. ICH (International Council for Harmonisation). (1997). ICH Harmonised Tripartite Guideline Q5D: Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products. ICH, Current Step 4 version, July 1997. https://database.ich.org/sites/default/files/Q5D%20Guideline.pdf

11장 — 생산 바이오리액터 모델링하기: 공정, 그 단계, 그리고 그 파라미터​

  1. FDA (U.S. Food and Drug Administration). (2004). Guidance for Industry: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. FDA, CDER/CVM/ORA, September 2004. https://www.fda.gov/media/71012/download
  2. IEC (International Electrotechnical Commission). (2010). IEC 61512-1: Batch control — Part 1: Models and terminology (ISA-88). IEC, Geneva. https://webstore.iec.ch/publication/5529
  3. Abu-Absi NR, Kenty BM, Cuellar ME, Borys MC, Sakhamuri S, Strachan DJ, Hausladen MC, Li ZJ. (2011). Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in-line Raman spectroscopy probe. Biotechnology and Bioengineering 108(5):1215-1221. https://doi.org/10.1002/bit.23023
  4. Das S, Sundara S, Cyganiak R (eds). (2012). R2RML: RDB to RDF Mapping Language. W3C Recommendation, 27 September 2012 (RML 확장 포함: RDF Mapping Language, IDLab/Ghent University, https://rml.io/specs/rml/). https://www.w3.org/TR/r2rml/
  5. Haller A, Janowicz K, Cox S, Le Phuoc D, Taylor K, Lefrançois M (eds). (2017). Semantic Sensor Network Ontology (SOSA/SSN). W3C / OGC Recommendation, 19 October 2017. https://www.w3.org/TR/vocab-ssn/
  6. AVEVA (formerly OSIsoft). (2023). PI Web API Reference — RESTful interface to the AVEVA/OSIsoft PI System. AVEVA Group plc. https://docs.aveva.com/bundle/pi-web-api-reference/page/help.html

12장 — 수확과 청징 모델링하기: 물질 변환​

  1. Shukla AA, Thömmes J. (2010). Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends in Biotechnology 28(5):253-261. https://doi.org/10.1016/j.tibtech.2010.02.001
  2. Liu HF, Ma J, Winter C, Bayer R. (2010). Recovery and purification process development for monoclonal antibody production. mAbs 2(5):480-499. https://doi.org/10.4161/mabs.2.5.12645
  3. IEC (International Electrotechnical Commission). (2010). IEC 61512-1: Batch control — Part 1: Models and terminology (ISA-88). IEC, Geneva. https://webstore.iec.ch/publication/5529

13장 — 포획 크로마토그래피와 풀링 문제 모델링하기​

  1. Shukla AA, Thömmes J. (2010). Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends in Biotechnology 28(5):253-261. https://doi.org/10.1016/j.tibtech.2010.02.001
  2. Liu HF, Ma J, Winter C, Bayer R. (2010). Recovery and purification process development for monoclonal antibody production. mAbs 2(5):480-499. https://doi.org/10.4161/mabs.2.5.12645
  3. Rathore AS, Parr L, Dermawan S, Lawson K, Lu Y. (2010). Large scale demonstration of a process analytical technology application in bioprocessing: use of on-line high performance liquid chromatography for making real time pooling decisions for process chromatography. Biotechnology Progress 26(2):448-457. https://doi.org/10.1002/btpr.320

14장 — 바이러스 안전 모델링하기: 위험을 줄이는 단계로서의 불활화와 여과​

  1. ICH (International Council for Harmonisation). (2023). ICH Harmonised Guideline Q5A(R2): Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. ICH, Current Step 4 version, November 2023. https://database.ich.org/sites/default/files/ICH_Q5A%28R2%29_Guideline_2023_1101.pdf
  2. Shukla AA, Thömmes J. (2010). Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends in Biotechnology 28(5):253-261. https://doi.org/10.1016/j.tibtech.2010.02.001
  3. Liu HF, Ma J, Winter C, Bayer R. (2010). Recovery and purification process development for monoclonal antibody production. mAbs 2(5):480-499. https://doi.org/10.4161/mabs.2.5.12645

15장 — 폴리싱 모델링하기: 다단계 정제와 품질 속성​

  1. Liu HF, Ma J, Winter C, Bayer R. (2010). Recovery and purification process development for monoclonal antibody production. mAbs 2(5):480-499. https://doi.org/10.4161/mabs.2.5.12645
  2. Shukla AA, Thömmes J. (2010). Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends in Biotechnology 28(5):253-261. https://doi.org/10.1016/j.tibtech.2010.02.001
  3. Fekete S, Beck A, Veuthey JL, Guillarme D. (2015). Ion-exchange chromatography for the characterization of biopharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis 113:43-55. https://doi.org/10.1016/j.jpba.2015.02.037

16장 — 원료의약품 모델링하기: 출하를 고정하는 로트​

  1. ICH (International Council for Harmonisation). (1999). ICH Harmonised Tripartite Guideline Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH, Current Step 4 version, March 1999. https://database.ich.org/sites/default/files/Q6B%20Guideline.pdf
  2. Liu HF, Ma J, Winter C, Bayer R. (2010). Recovery and purification process development for monoclonal antibody production. mAbs 2(5):480-499. https://doi.org/10.4161/mabs.2.5.12645
  3. Shukla AA, Thömmes J. (2010). Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends in Biotechnology 28(5):253-261. https://doi.org/10.1016/j.tibtech.2010.02.001

17장 — 제형화와 충전·마감 모델링하기: 원료의약품에서 완제의약품으로​

  1. Daugherty AL, Mrsny RJ. (2006). Formulation and delivery issues for monoclonal antibody therapeutics. Advanced Drug Delivery Reviews 58(5-6):686-706. https://doi.org/10.1016/j.addr.2006.03.011
  2. ICH (International Council for Harmonisation). (1999). ICH Harmonised Tripartite Guideline Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH, Current Step 4 version, March 1999. https://database.ich.org/sites/default/files/Q6B%20Guideline.pdf
  3. FDA (U.S. Food and Drug Administration). (1999). Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. FDA, CDER/CBER, May 1999. https://www.fda.gov/media/70788/download

18장 — QC와 출하 관문 모델링하기: SHACL로서의 규격​

  1. Knublauch H, Kontokostas D (eds). (2017). Shapes Constraint Language (SHACL). W3C Recommendation, 20 July 2017. https://www.w3.org/TR/shacl/
  2. ICH (International Council for Harmonisation). (1999). ICH Harmonised Tripartite Guideline Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH, Current Step 4 version, March 1999. https://database.ich.org/sites/default/files/Q6B%20Guideline.pdf
  3. FDA (U.S. Food and Drug Administration). (1997). 21 CFR Part 11 — Electronic Records; Electronic Signatures. U.S. Code of Federal Regulations, Title 21, Part 11 (with EU GMP Annex 11, Computerised Systems, as the European counterpart). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11

19장 — 포장과 일련번호 부여 모델링하기: GS1과 단위 식별​

  1. GS1. (2024). GS1 General Specifications (Release 24). GS1 AISBL, Brussels. https://www.gs1.org/standards/barcodes-epcrfid-id-keys/gs1-general-specifications
  2. GS1. (2022). EPCIS and Core Business Vocabulary (CBV) Standard, Release 2.0. GS1 AISBL, Brussels. https://www.gs1.org/standards/epcis
  3. FDA (U.S. Food and Drug Administration). (2013). Drug Supply Chain Security Act (DSCSA), Title II of the Drug Quality and Security Act. U.S. FDA (with EU Directive 2011/62/EU, the Falsified Medicines Directive, as the European counterpart). https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa

20장 — 유통과 환자까지의 콜드체인 모델링하기​

  1. European Commission. (2013). Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01). Official Journal of the European Union. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52013XC1123%2801%29
  2. WHO (World Health Organization). (2011). Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products. WHO Technical Report Series No. 961, Annex 9. https://www.who.int/publications/m/item/storage-transport-trs961-annex9
  3. USP (United States Pharmacopeia). (2023). General Chapter 1079: Good Storage and Distribution Practices for Drug Products. United States Pharmacopeia–National Formulary (USP–NF). https://www.usp.org/

21장 — 디지털 스레드 조립하기: 계보, 영향, 그리고 전체 수명주기 질의​

  1. Harris S, Seaborne A (eds). (2013). SPARQL 1.1 Query Language. W3C Recommendation, 21 March 2013. https://www.w3.org/TR/sparql11-query/
  2. Kritzinger W, Karner M, Traar G, Henjes J, Sihn W. (2018). Digital Twin in manufacturing: A categorical literature review and classification. IFAC-PapersOnLine 51(11):1016-1022. https://doi.org/10.1016/j.ifacol.2018.08.474
  3. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data 3:160018. https://doi.org/10.1038/sdata.2016.18

22장 — 모델 거버넌스: 버전 관리, 변경 통제, 온톨로지 관리​

  1. Moxon SAT, Solbrig H, Unni DR, et al. (2021). The Linked Data Modeling Language (LinkML): A General-Purpose Data Modeling Framework Grounded in Machine-Readable Semantics. Proceedings of the International Conference on Biomedical Ontologies (ICBO 2021), CEUR-WS Vol. 3073. https://ceur-ws.org/Vol-3073/
  2. Smith B, Ashburner M, Rosse C, et al. (2007). The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nature Biotechnology 25(11):1251-1255. https://doi.org/10.1038/nbt1346
  3. ISPE (International Society for Pharmaceutical Engineering). (2022). GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition). ISPE, July 2022. https://guidance-docs.ispe.org/doi/book/10.1002/9781946964571

23장 — 실무에서의 FAIR: 그래프가 실제로 성과를 내는지 측정하기​

  1. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data 3:160018. https://doi.org/10.1038/sdata.2016.18
  2. Wilkinson MD, Sansone SA, Schultes E, Doorn P, Bonino da Silva Santos LO, Dumontier M. (2018). A design framework and exemplar metrics for FAIRness. Scientific Data 5:180118. https://doi.org/10.1038/sdata.2018.118
  3. Jacobsen A, de Miranda Azevedo R, Juty N, et al. (2020). FAIR Principles: Interpretations and Implementation Considerations. Data Intelligence 2(1-2):10-29. https://doi.org/10.1162/dint_r_00024

24장 — 표준 기관: 바이오파마의 공유 어휘를 실제로 만드는 주체​

  1. Allotrope Foundation. (2024). About the Allotrope Foundation (founding history; Foundation Members; framework). Allotrope Foundation. https://www.allotrope.org/about-us
  2. Allotrope Foundation. (2024). Allotrope Foundation Ontologies (AFO). Allotrope Foundation. https://www.allotrope.org/ontologies
  3. Pistoia Alliance. (2024). Pistoia Alliance Launches Freely Available IDMP Ontology 1.0. Press release, 24 January 2024. https://pistoiaalliance.org/news/press-release-pistoia-alliance-launches-idmp-1-0/
  4. Pistoia Alliance. (2024). About the Pistoia Alliance (founders, founding year, membership). https://pistoiaalliance.org/membership/about/
  5. Pistoia Alliance. (2026). Pistoia Alliance Releases Version 1.0 of the Pharmaceutical CMC Process Ontology. https://pistoiaalliance.org/news/pistoia-alliance-releases-version-1-0-of-the-pharmaceutical-cmc-process-ontology/
  6. MESA International. (2020). B2MML — Business To Manufacturing Markup Language, Version 7 (V0700) (W3C XSD implementation of the ISA-95 / IEC 62264 family). Manufacturing Enterprise Solutions Association. https://mesa.org/topics-resources/b2mml/
  7. OPC Foundation. (2013). OPC 10030 — OPC UA for ISA-95 Common Object Model, Release 1.00. OPC Foundation. https://reference.opcfoundation.org/specs/OPC-10030
  8. PROFIBUS & PROFINET International (PI). (2024). MTP — Module Type Packages (VDI/VDE/NAMUR 2658; toward IEC 63280). https://www.profibus.com/technologies/mtp
  9. ISPE (International Society for Pharmaceutical Engineering). (2023). ISPE Baseline Guide Vol. 8: Pharma 4.0 (First Edition). ISPE, December 2023. https://ispe.org/publications/guidance-documents/baseline-guide-vol-8-pharma-40-1st-edition
  10. BioPhorum. (2023). Digital Plant Maturity Model 3.0. BioPhorum Operations Group, October 2023. https://www.biophorum.com/workstream/dpmm-v-3/
  11. GS1 US. (2024). Applying the GS1 System of Standards for DSCSA and Serialized Interoperable Traceability. GS1 US. https://www.gs1us.org/
  12. NIIMBL / Open Applications Group (OAGi). (2024). NIIMBL and OAGi Partner to Develop Open-Source Biopharmaceutical Manufacturing Ontologies. Press release, June 2024. https://www.prnewswire.com/news-releases/niimbl-and-open-applications-group-oagi-partner-to-develop-open-source-biopharmaceutical-manufacturing-ontologies-302172016.html

25장 — 실제로 쓰이는 어휘: AFO에서 IDMP까지​

  1. Allotrope Foundation. (2024). Allotrope Foundation Ontologies (AFO). Allotrope Foundation. https://www.allotrope.org/ontologies
  2. Rise of the Allotrope Simple Model (ASM). (2024). Drug Discovery Today. https://www.sciencedirect.com/science/article/abs/pii/S1359644624000692
  3. EMA (European Medicines Agency). (2024). Data on medicines (ISO IDMP standards): Overview. https://www.ema.europa.eu/en/human-regulatory-overview/research-development/data-medicines-iso-idmp-standards-overview
  4. FDA (U.S. Food and Drug Administration). (2021). FDA's Global Substance Registration System (GSRS) / UNII. FDA. https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system
  5. CDISC. (2024). CDISC Controlled Terminology (distributed via the NCI Thesaurus / NCI-EVS). https://www.cdisc.org/standards/terminology/controlled-terminology
  6. EMBL-EBI. (2024). ChEBI — Chemical Entities of Biological Interest. European Bioinformatics Institute. https://www.ebi.ac.uk/chebi/
  7. QUDT.org. (2024). QUDT — Quantities, Units, Dimensions and Types Ontology. QUDT.org. https://qudt.org/
  8. Schadow G, McDonald CJ. (2017). The Unified Code for Units of Measure (UCUM), Revision 2.1. Regenstrief Institute, Indianapolis, IN. https://ucum.org/
  9. Abeyruwan S, Vempati UD, Küçük-McGinty H, et al. (2014). Using the BioAssay Ontology for analyzing high-throughput screening data. Journal of Biomolecular Screening / SLAS Discovery 19(5):715-726. https://journals.sagepub.com/doi/10.1177/1087057114563493
  10. Batchelor C, et al. CHMO — the Chemical Methods Ontology. OBO Foundry. http://obofoundry.org/ontology/chmo.html
  11. OBO Foundry. PROCO — Process Chemistry Ontology. https://obofoundry.org/ontology/proco.html
  12. Natale DA, Arighi CN, Blum M, et al. (2017). Protein Ontology (PRO): enhancing and scaling up the representation of protein entities. Nucleic Acids Research 45(D1):D339-D346. https://doi.org/10.1093/nar/gkw1075
  13. Lebo T, Sahoo S, McGuinness D (eds). (2013). PROV-O: The PROV Ontology. W3C Recommendation, 30 April 2013. https://www.w3.org/TR/prov-o/

26장 — 플랫폼: 벤더는 시맨틱을 어떻게 파는가​

  1. TetraScience. (2024). Creating Data in the Allotrope Simple Model (ASM) at Scale. Factsheet. https://www.tetrascience.com/factsheet/creating-data-in-the-allotrope-simple-model
  2. SciBite (an Elsevier company). (2024). SciBite Brings Enterprise Ontologies to Benchling: Ontology-Backed Data Capture. https://scibite.com/knowledge-hub/news/benchling-ontology-backed-data-capture/
  3. Revvity Signals. (2024). Signals One — Ontology Support. https://revvitysignals.com/products/research/signals-one
  4. Körber. (2024). Werum PAS-X MES — MBR Design & Execution. Körber Pharma. https://www.koerber-pharma.com/en/solutions/software/werum-pas-x-mes-suite/werum-pas-x-mbr-design-execution
  5. AVEVA (formerly OSIsoft). (2023). What is PI Asset Framework?. AVEVA Group plc. https://www.aveva.com/en/perspectives/blog/easy-as-pi-asset-framework/
  6. Palantir Technologies. (2024). Foundry Ontology — Overview. https://www.palantir.com/docs/foundry/ontology/overview
  7. Stardog. (2024). Customer Story: Boehringer Ingelheim. https://www.stardog.com/company/customers/boehringer-ingelheim/
  8. Ontotext. (2023). Ontotext's New AI-Powered Target Discovery Solution. PR Newswire, 15 May 2023. https://www.prnewswire.com/news-releases/ontotexts-new-ai-powered-target-discovery-solution-enables-life-sciences-companies-to-achieve-10x-more-efficient-insight-discovery-and-4x-faster-information-retrieval-301824722.html
  9. Neo4j. (2025). GraphTalk Pharma & Life Sciences 2025 — A Recap. https://neo4j.com/blog/developer/graphtalk-pharma-life-sciences-2025/
  10. Das S, Sundara S, Cyganiak R (eds). (2012). R2RML: RDB to RDF Mapping Language. W3C Recommendation, 27 September 2012 (with the RML extension, https://rml.io/specs/rml/). https://www.w3.org/TR/r2rml/

27장 — 빅파마의 엔터프라이즈 지식 그래프​

  1. Pistoia Alliance FAIR Toolkit. (2024). FAIR Data by Design — Roche. https://fairtoolkit.pistoiaalliance.org/use-cases/fair-data-by-design/
  2. metaphacts. (2024). Knowledge Democratization with an Enterprise Knowledge Graph at Boehringer Ingelheim. https://metaphacts.com/knowledge-democratization-with-an-enterprise-knowledge-graph-at-boehringer-ingelheim
  3. Phenome-wide identification of therapeutic genetic targets (Mantis-ML 2.0 with the AstraZeneca Biological Insights Knowledge Graph). (2024). Science Advances. https://pmc.ncbi.nlm.nih.gov/articles/PMC11078195/
  4. Novartis. (2024). The data42 Program and Ontology Designer — data42 (careers). https://www.novartis.com/stories/data42-program-shows-novartis-intent-go-big-data-and-digital
  5. Digital evolution: Novo Nordisk's shift to ontology-based data management. (2025). Journal of Biomedical Semantics 16. https://link.springer.com/article/10.1186/s13326-025-00327-4
  6. Pistoia Alliance. (2026). Pistoia Alliance Advances IDMP Ontology (J&J production product master). https://pistoiaalliance.org/news/pistoia-alliance-advances-idmp-ontology/
  7. BioProcess International. (2024). Adding Context: Data Mapping Key to Sanofi's Digitization Strategy. https://www.bioprocessintl.com/upstream-downstream-processing/adding-context-data-mapping-key-to-sanofi-s-digitization-strategy
  8. The Pistoia Alliance's methods database project: machine-readable HPLC-UV method transfer via the Allotrope Data Format. (2025). Journal of Pharmaceutical and Biomedical Analysis. https://pubmed.ncbi.nlm.nih.gov/40286673/

28장 — 규제 시맨틱: IDMP, SPL, KASA, 그리고 구조화된 제출​

  1. EMA (European Medicines Agency). (2024). Data on medicines (ISO IDMP standards); Substance, Product, Organisation and Referential (SPOR) master data; PMS go-live notices. https://www.ema.europa.eu/en/human-regulatory-overview/research-development/data-medicines-iso-idmp-standards-overview
  2. Galata SR, et al. (2021). The Global Substance Registration System (GSRS). Nucleic Acids Research 49(D1):D1179-D1185; FDA, GSRS / UNII. https://academic.oup.com/nar/article/49/D1/D1179/5952203
  3. FDA (U.S. Food and Drug Administration). (2024). Structured Product Labeling (SPL) Resources. https://www.fda.gov/industry/fda-data-standards-advisory-board/structured-product-labeling-resources
  4. CDISC; U.S. Federal Register. (2021). CDISC SEND (Standard for Exchange of Nonclinical Data); Technical Rejection Criteria for Study Data, Federal Register, 29 July 2021. https://www.cdisc.org/standards/foundational/send
  5. FDA's implementation of KASA (Knowledge-Aided Assessment and Structured Application) for manufacturing assessment of non-sterile solid oral dosage forms. (2025). AAPS Open. https://link.springer.com/article/10.1186/s41120-025-00141-3
  6. HL7 / FDA. (2024). PQ-CMC: Pharmaceutical Quality / Chemistry, Manufacturing and Controls FHIR Implementation Guide, v2.0.0. http://hl7.org/fhir/us/pq-cmc-fda/
  7. FDA (U.S. Food and Drug Administration). (2024). eCTD Submission Standards for eCTD v4.0 and Regional M1. https://www.fda.gov/drugs/electronic-regulatory-submission-and-review/ectd-submission-standards-ectd-v40-and-regional-m1
  8. ICH / ICMRA. (2025-2026). ICH M4Q(R2) draft guideline (Step 2); ICMRA Pharmaceutical Quality Knowledge Management — Unique Identifier Progress Report. https://www.federalregister.gov/documents/2026/01/21/2026-01073/ ; https://icmra.info/
  9. Pistoia Alliance. (2026). IDMP Ontology (IDMP-O) project; standardization via ISO/TS 21405. https://pistoiaalliance.org/project/idmp-o/
  10. Schadow G, McDonald CJ. (2017). The Unified Code for Units of Measure (UCUM), Revision 2.1. Regenstrief Institute, Indianapolis, IN. https://ucum.org/
  11. ISPE. (2022). GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition); FDA, 21 CFR Part 11 — Electronic Records; Electronic Signatures (with EU GMP Annex 11). https://guidance-docs.ispe.org/doi/book/10.1002/9781946964571

29장 — 제조 현장과 디지털 트윈: 온톨로지가 아직 도착 중인 곳​

  1. Putting Together the Pieces (Genentech SAP-IDoc-to-B2MML integration). Pharmaceutical Technology; AVEVA, What is PI Asset Framework?. https://www.pharmtech.com/view/putting-together-pieces
  2. ISPE. (2023). A Simplified Integration of Qualified Laboratory Devices with the Asset Administration Shell as the Digital Twin. ISPE White Paper, May 2023. https://ispe.org/pharmaceutical-engineering/white-papers/simplified-integration-qualified-laboratory-devices-asset-administration
  3. SiLA Consortium / UniteLabs. (2024). UniteLabs Tecan FluentControl Connector (SiLA 2); The AC/DC Concept (Drug Discovery World). https://sila-standard.com/sila_device/unitelabs-tecan-fluentcontrol-connector/
  4. OPC Foundation. (2025). SPECTARIS LADS Showcases Integration of OPC UA with Allotrope Standards; OPC 30500 — LADS (Laboratory and Analytical Device Standard). https://opcfoundation.org/news/press-releases/breakthrough-in-smarter-labs-spectaris-lads-showcases-integration-of-opc-ua-with-allotrope-standards/
  5. Haller A, Janowicz K, Cox S, Le Phuoc D, Taylor K, Lefrançois M (eds). (2017). Semantic Sensor Network Ontology (SOSA/SSN). W3C / OGC Recommendation, 19 October 2017. https://www.w3.org/TR/vocab-ssn/
  6. BioPhorum. (2023). Big Data to Smart Data: Implementing an Ontology and Digital Data Capture to Improve Biomanufacturing. BioPhorum, 29 November 2023. https://www.biophorum.com/download/big-data-to-smart-data-implementing-an-ontology-and-digital-data-capture-to-improve-biomanufacturing/
  7. Digital Twins in Biopharmaceutical Manufacturing: Review and Perspective. (2025). arXiv preprint; with Samsung Biologics CFD twin (Pharma's Almanac) and GSK vaccine twin (Fierce Pharma). https://arxiv.org/pdf/2504.00286
  8. NIST (National Institute of Standards and Technology). (2023). Towards Ontologizing a Digital Twin Framework for Manufacturing (ISO 23247; BFO + IOF Core; bioreactor example). IFIP APMS 2023. https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=936637
  9. MCBO — the Mammalian Cell Bioprocessing Ontology. (2026). bioRxiv preprint (not yet peer-reviewed). https://www.biorxiv.org/content/10.64898/2026.01.05.697007v1
  10. Industrial Ontologies Foundry / OAGi / NIIMBL. (2024-2025). Open-source biopharmaceutical-manufacturing (IOF Biopharma) reference ontologies. https://github.com/iofoundry/ontology/releases
  11. ISPE. (2020). Continued Process Verification in Stages 1-3; MilliporeSigma, Bio4C ProcessPad; Multivariate Data-Driven Modeling for Continued Process Verification, BioProcess International. https://ispe.org/pharmaceutical-engineering/july-august-2020/continued-process-verification-stages-1-3

30장 — 프런티어: AI의 그라운드 트루스로서의 온톨로지​

  1. Pistoia Alliance. (2025). Pistoia Alliance Launches Third Phase of the CMC Process Ontology (making life-sciences data "AI-ready"). https://pistoiaalliance.org/news/pistoia-alliance-launches-third-phase-of-cmc-process-ontology/
  2. TetraScience. (2024-2025). TetraScience Collaborates with NVIDIA (BusinessWire, 12 November 2024); TetraScience Launches the Scientific AI Lighthouse (SAIL) Program with Takeda as Founding Partner (PR Newswire, 23 October 2025). https://www.businesswire.com/news/home/20241112651874/en/
  3. Neo4j. (2025). GraphTalk Pharma & Life Sciences 2025 — A Recap (Merck Group Synaptix; Bayer; Syngenta NOCTIS). https://neo4j.com/blog/developer/graphtalk-pharma-life-sciences-2025/
  4. Digital evolution: Novo Nordisk's shift to ontology-based data management. (2025). Journal of Biomedical Semantics 16. https://link.springer.com/article/10.1186/s13326-025-00327-4
  5. Rise of the Allotrope Simple Model (ASM). (2024). Drug Discovery Today. https://www.sciencedirect.com/science/article/abs/pii/S1359644624000692
  6. PROFIBUS & PROFINET International. (2025-2026). First MTP V2.0 Plugfest Successfully Completed; PI Publishes MTP Specification 2.0. https://www.profibus.com/newsroom/press-news/first-mtp-v20-plugfest-successfully-completed
  7. Digital Twins in Biopharmaceutical Manufacturing: Review and Perspective. (2025). arXiv preprint (the data-standardization bottleneck thesis). https://arxiv.org/pdf/2504.00286

31장 — 솔직한 평가: 온톨로지가 해결하는 것과 사람에게 남기는 것​

  1. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data 3:160018. https://doi.org/10.1038/sdata.2016.18
  2. Smith B, Ashburner M, Rosse C, et al. (2007). The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nature Biotechnology 25(11):1251-1255. https://doi.org/10.1038/nbt1346
  3. ISO/IEC (International Organization for Standardization / International Electrotechnical Commission). (2021). ISO/IEC 21838-2:2021 — Information technology — Top-level ontologies (TLO) — Part 2: Basic Formal Ontology (BFO). ISO/IEC, Geneva. https://www.iso.org/standard/74572.html